Small Cash Component Delaying Opioid Deal, Says ‘Optimistic’ Teva
Hoping To Announce Settlement ‘In The Coming Year’
Teva CEO Kåre Schultz has spoken at great length and in great detail about Teva’s ability to reach a proposed settlement in the US over allegations the firm helped fuel the opioid epidemic, revealing that a deal may be only 12 months away.
